Combined treatment of palmoplantar syndrome in patients under antitumor therapy
Kruglova, L.S.; Shatokhina, E.A.; Elfimov, M.A.; Illarionov, V.E.; Chervinskaya, A.V.; Portnov, V.V.; Filatova, E.V.; Petrova, M.S.
Meditsina Truda i Promyshlennaia Ekologiia 2: 21-24
2016
ISSN/ISBN: 1026-9428 PMID: 27164748 Document Number: 688633
Observation covered 12 patients under various antitumor medications. Group 1 was formed of patients with developed palmoplantar syndrome varying in severity, who received complex treatment including IR-therapy and local antioxidant medication. Group 2 included patients without palmoplantar syndrome, who received preventive treatment with IR-therapy. All patients of group 1 demonstrated lower severity of palmoplantar syndrome manifestations. In group 2, 80% of the patients avoided palmoplantar syndrome development, and 20% of the patients had light course of the syndrome manifestations. Patients at high risk of palmoplantar syndrome under antitumor therapy are recommended to undergo IR-therapy and local antioxidant medication.